Pharmiva AB (publ) (PHARM.ST) Research

Pharmiva AB (publ), a Swedish company based in Lund, specializes in the research and development of medical products. Its flagship product is Vernivia, an over-the-counter vaginal mousse formulated for the treatment of bacterial vaginosis.

Market snapshot

Symbol
PHARM.ST
Price
$0.56
Day change
-16.17%
Market cap
$12.9M
P/E ratio
-0.41x
52-week range
0.56-2.32
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • AegirBio AB (publ) (AEGIR.ST)
  • Amniotics AB (publ) (AMNI.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Diagonal Bio AB (publ) (DIABIO.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Learning 2 Sleep L2S AB (publ) (L2S.ST)
  • Pexa AB (PEXAB.ST)
  • Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST)

Open Pharmiva AB (publ) (PHARM.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.